Chemoinformaics analysis of 2-Nitro-1,5-P-Menthadiene
Molecular Weight | 181.235 | nRot | 2 |
Heavy Atom Molecular Weight | 166.115 | nRig | 7 |
Exact Molecular Weight | 181.11 | nRing | 1 |
Solubility: LogS | -3.365 | nHRing | 0 |
Solubility: LogP | 3.074 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 29.4059 |
nHD | 0 | BPOL | 16.2141 |
QED | 0.485 |
Synth | 3.884 |
Natural Product Likeliness | 0.861 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.338 |
MDCK | 0.000178434 |
BBB | 0.911 |
PPB | 0.905134 |
VDSS | 1.037 |
FU | 0.0699104 |
CYP1A2-inh | 0.297 |
CYP1A2-sub | 0.511 |
CYP2c19-inh | 0.682 |
CYP2c19-sub | 0.85 |
CYP2c9-inh | 0.389 |
CYP2c9-sub | 0.212 |
CYP2d6-inh | 0.055 |
CYP2d6-sub | 0.415 |
CYP3a4-inh | 0.226 |
CYP3a4-sub | 0.656 |
CL | 8.525 |
T12 | 0.66 |
hERG | 0.028 |
Ames | 0.185 |
ROA | 0.126 |
SkinSen | 0.942 |
Carcinogencity | 0.94 |
EI | 0.762 |
Respiratory | 0.958 |
NR-Aromatase | 0.036 |
Antiviral | No |
Prediction | 0.922743 |